Galbraith Kenneth is a corporate insider with SEC Form 4 filings on record. No transactions have been reported in the past 12 months. Historical filings, if any, are searchable below.

Galbraith Kenneth

CEO

Latest Insider Transactions

10 transactions (past 365 days)

ZYME
CEO
Award
$0
216,000 shares @ $0.00
Filed 2026-01-12Trade 2026-01-12
Zymeworks Inc.
ZYME
CEO
Sale
-$689.8K
30,424 shares @ $22.67
Filed 2026-01-12Trade 2026-01-12
Zymeworks Inc.
ZYME
CEO
Exercise Conversion
$0
64,000 shares @ $0.00
Filed 2026-01-12Trade 2026-01-12
Zymeworks Inc.
ZYME
CEO
Sale
-$795.2K
31,686 shares @ $25.10
Filed 2026-01-05Trade 2026-01-05
Zymeworks Inc.
ZYME
CEO
Exercise Conversion
$0
47,668 shares @ $0.00
Filed 2026-01-05Trade 2026-01-05
Zymeworks Inc.
ZYME
CEO
Exercise Conversion
$0
66,666 shares @ $0.00
Filed 2026-01-05Trade 2026-01-05
Zymeworks Inc.
ZYME
CEO
Sale
-$568.6K
22,657 shares @ $25.10
Filed 2026-01-05Trade 2026-01-05
Zymeworks Inc.
ZYME
CEO
Exercise Conversion
$0
100,000 shares @ $0.00
Filed 2025-12-22Trade 2025-12-22
Zymeworks Inc.
ZYME
CEO
Sale
-$1.3M
47,528 shares @ $27.02
Filed 2025-12-22Trade 2025-12-22
Zymeworks Inc.
ZYME
CEO
Exercise Conversion
$0
100,000 shares @ $0.00
Filed 2025-12-22Trade 2025-12-22
Zymeworks Inc.